|1.||Bang, Yung-Jue: 3 articles (09/2006 - 08/2004)|
|2.||Kim, Tae-You: 2 articles (09/2006 - 08/2004)|
|3.||Kim, Tai Young: 2 articles (09/2006 - 08/2004)|
|4.||Jong, Hyun-Soon: 2 articles (09/2006 - 08/2004)|
|5.||Kim, Noe Kyeong: 2 articles (09/2006 - 08/2004)|
|6.||Park, Jung-Hyun: 2 articles (09/2006 - 08/2004)|
|7.||Kim, Sang Gyun: 2 articles (09/2006 - 08/2004)|
|8.||Kim, In Ah: 1 article (12/2013)|
|9.||Kim, Jin Ho: 1 article (12/2013)|
|10.||Kim, Hak Jae: 1 article (12/2013)|
09/01/2006 - "Moreover, SK-7041 inhibited cancer cell proliferation more selectively than NHBE cell proliferation. "
09/01/2006 - "SK-7041 induced time-dependent histone hyperacetylation and showed more potent cytotoxicity than SAHA in cancer cells. "
08/01/2004 - "Finally, in vivo experiment showed that SK-7041 or SK-7068 was found to reduce the growth of implanted human tumors in nude mice. "
08/01/2004 - "In this study we evaluated the antitumor effects of these novel hybrid synthetic HDAC inhibitors, SK-7041 and SK-7068, on human cancer cells. "
|2.||Breast Neoplasms (Breast Cancer)
09/01/2006 - "In this study, the antitumor effects of SK-7041, one of those novel HDAC inhibitors, was evaluated on lung and breast cancer cell lines. "
09/01/2006 - "Human lung and breast cancer cells, as well as normal human bronchial epithelial (NHBE) cells were treated with SK-7041, and results were compared with those of cells treated with suberoylanilide hydroxamic acid (SAHA). "
09/01/2006 - "Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells."
|3.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/01/2007 - "SK-7041 showed synergism on growth inhibition, cell cycle arrest and induction of apoptosis in chronic myeloid leukemia (K562) when combined with STI571. "
07/01/2007 - "Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia."
07/01/2007 - "Taken together, our findings suggest that SK-7041 is active against leukemia and offers new prospects for overcoming STI571 resistance in chronic myeloid leukemia."
|4.||Stomach Neoplasms (Stomach Cancer)
|5.||Pancreatic Neoplasms (Pancreatic Cancer)
|1.||Histone Deacetylase Inhibitors
|3.||trichostatin A (A 300)
|6.||Valproic Acid (Valproate, Semisodium)
|9.||vorinostat (suberoylanilide hydroxamic acid)